Mochida Pharmaceutical Co (TSE:4534) Total Current Assets : 円113,522 Mil (As of Dec. 2023)

View and export this data going back to 1963. Start your Free Trial

What is Mochida Pharmaceutical Co Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Mochida Pharmaceutical Co's total current assets for the quarter that ended in Dec. 2023 was 円113,522 Mil.

Mochida Pharmaceutical Co Total Current Assets Historical Data

The historical data trend for Mochida Pharmaceutical Co's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mochida Pharmaceutical Co Total Current Assets Chart

Mochida Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Current Assets

Get a 7-Day Free Trial

116,894.00

118,793.00

121,448.00

117,379.00

116,662.00

Mochida Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Current Assets	Get a 7-Day Free Trial															117,379.00	115,390.00	112,253.00	113,522.00	116,662.00

Mochida Pharmaceutical Co Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Mochida Pharmaceutical Co's Total Current Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	46789	+	34838	+	30278	+	4757
	=	116,662

Mochida Pharmaceutical Co's Total Current Assets for the quarter that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	43408	+	35093	+	29782	+	5239
	=	113,522

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Mochida Pharmaceutical Co (TSE:4534) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Mochida Pharmaceutical Co's Liquidation Value for the quarter that ended in Dec. 2023 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	43408	-	30648	+	0.75 * 35093	+	0.5 * 29782
=	53,971

Mochida Pharmaceutical Co Total Current Assets Related Terms

Thank you for viewing the detailed overview of Mochida Pharmaceutical Co's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Mochida Pharmaceutical Co (TSE:4534) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mochida Pharmaceutical Co Ltd (TSE:4534) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-1 Ichigayahonmuracho, Shinjuku-ku, Tokyo, JPN, 162-0845

Website

http://www.mochida.co.jp

Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.

Mochida Pharmaceutical Co (TSE:4534) Headlines

No Headlines